新路易斯湖标准在儿童心肌炎中的应用价值研究

doi:10.12372/jcp.2024.23e0289

Abstract

Abstract:

Objective To explore the application value of new Lake Louise criteria (LLC) in the diagnosis of myocarditis in children. Methods The clinical data of children diagnosed with myocarditis (myocarditis group) in Children's Hospital Affiliated to Zhejiang University School of Medicine from May 2019 to December 2020 were retrospectively analyzed. In addition, children who were clinically excluded from myocarditis during the same period were included as non-myocarditis group. Receiver operating characteristic (ROC) curve analysis and calculation of Kappa value were used to compare the diagnostic efficacy of LLC and new LLC in children with myocarditis. Results In the myocarditis group, there were 29 children (16 boys and 13 girls) with a median age of 8.8 (4.2-13.4) years. There were 50 patients (27 boys and 23 girls) in the non-myocarditis group, and the median age was 9.7 (6.2-13.2) years. The T2 mapping value, T1 native value and ECV value of myocarditis group were higher than those of non-myocarditis group, the T1 enhanced value was lower than that of non-myocarditis group, and the difference was statistically significant (P<0.05). The area under ROC curves (AUCs) of LLC, T2 mapping, T1 native, T1 enhanced and ECV for diagnosing myocarditis were 0.75, 0.86, 0.92, 0.70 and 0.93, respectively. The accuracy, sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio of LLC in diagnosing myocarditis were 81.0%, 51.7%, 98.0%, 93.8%, 77.8%, 25.85 and 0.49 respectively. The consistency between LLC and the clinical diagnosis of myocarditis was moderate (Kappa=0.55, P<0.001). The accuracy, sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio of new LLC in diagnosing myocarditis were 92.4%, 89.7%, 94.0%, 89.7%, 94.0%, 14.95 and 0.11 respectively. The consistency between new LLC and the clinical diagnosis of myocarditis was good (Kappa=0.84, P<0.001). Conclusions The new LLC has good application value in the diagnosis of myocarditis in children and can effectively improve the diagnostic efficiency.

Key words: new Lake Louise criteria, myocarditis, magnetic resonance, child

LIANG Jiawei, MA Xiaohui, JIA Xuan. Study on the application value of the new Lake Louise criteria in children with myocarditis[J].Journal of Clinical Pediatrics, 2024, 42(6): 526-532.

Figures/Tables 5

References 39

[1]	陈燕, 罗琳, 何健龙, 等. MRI T1 mapping、T2 mapping心肌分段在诊断急性心肌炎中的应用[J]. 中国医学影像学杂志, 2019, 27(8): 599-604.
[2]	Haaf P, Garg P, Messroghli DR, et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review[J]. J Cardiovasc Magn Reson, 2016, 18(1): 89.
[3]	Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper[J]. J Am Coll Cardiol, 2009, 53(17): 1475-1487. doi: 10.1016/j.jacc.2009.02.007 pmid: 19389557
[4]	Schumm J, Greulich S, Wagner A, et al. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis[J]. J Cardiovasc Magn Reson, 2014, 16(1): 14.
[5]	周笛, 庄白燕, 赵世华, 等. 心血管MR诊断心肌炎研究进展: 基于2018《非缺血性心肌炎症诊断CMR标准修改》专家推荐意见[J]. 中国医学影像技术, 2019, 35(10): 1574-1577.
[6]	Radunski UK, Lund GK, Stehning C, et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging[J]. JACC Cardiovasc Imaging, 2014, 7(7): 667-675. doi: 10.1016/j.jcmg.2014.02.005 pmid: 24954462
[7]	Bohnen S, Radunski UK, Lund GK, et al. Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure[J]. Circ Cardiovasc Imaging, 2015, 8(6): e003073.
[8]	Liu G, Yang X, Su Y, et al. Cardiovascular magnetic resonance imaging findings in children with myocarditis[J]. Chin Med J (Engl), 2014, 127(21): 3700-3705.
[9]	Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy[J]. Circ Cardiovasc Imaging, 2012, 5(6): 726-733. doi: 10.1161/CIRCIMAGING.112.976738 pmid: 23071146
[10]	赵世华. 迎接心脏磁共振成像新技术挑战[J]. 中国医学影像技术, 2017, 33(8): 1125-1128.
[11]	Luetkens JA, Homsi R, Sprinkart AM, et al. Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(2): 154-161. doi: 10.1093/ehjci/jev246 pmid: 26476398
[12]	Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations[J]. J Am Coll Cardiol, 2018, 72(24): 3158-3176. doi: S0735-1097(18)38843-0 pmid: 30545455
[13]	中华医学会儿科学分会心血管学组, 中华医学会儿科学分会心血管学组心肌炎协作组, 中华儿科杂志编辑委员会, 等. 儿童心肌炎诊断建议(2018年版)[J]. 中华儿科杂志, 2019, 57(2): 87-89.
[14]	Youn JC, Hong YH, Lee HJ, et al. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study[J]. Eur Radiol, 2017, 27(9): 3924-3933.
[15]	刘钢, 张兴梅, 温兆赢, 等. 心脏磁共振定量组织标记技术对急性心肌炎的诊断价值[J]. 中国医药, 2017, 12(1): 41-45.
[16]	陈文剑, 郭婷婷, 张继良, 等. 心脏磁共振对心肌炎的诊断价值[J]. 中国实用医刊, 2020, 47(9): 5-7.
[17]	欧阳海春, 陈海雄, 胡允兆, 等. 磁共振在急性病毒性心肌炎中的诊断价值[J]. 中华心血管病杂志, 2014, 42(11): 927-931.
[18]	Dabir D, Vollbrecht TM, Luetkens JA, et al. Multiparametric cardiovascular magnetic resonance imaging in acute myocarditis: a comparison of different measurement approaches[J]. J Cardiovasc Magn Reson, 2019, 21(1): 54.
[19]	Bami K, Haddad T, Dick A, et al. Noninvasive imaging in acute myocarditis[J]. Curr Opin Cardiol, 2016, 31(2): 217-223. doi: 10.1097/HCO.0000000000000265 pmid: 26731291
[20]	万俊义. 心脏磁共振钆对比剂延迟强化的临床意义及判断预后的价值[J]. 中国医学影像技术, 2012, 28(8): 1600-1603.
[21]	Banka P, Robinson JD, Uppu SC, et al. Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study[J]. J Cardiovasc Magn Reson, 2015, 17: 96.
[22]	Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis[J]. JACC Cardiovasc Imaging, 2012, 5(5): 513-524. doi: 10.1016/j.jcmg.2011.11.022 pmid: 22595159
[23]	Mavrogeni S, Bratis K, Georgakopoulos D, et al. Evaluation of myocarditis in a pediatric population using cardiovascular magnetic resonance and endomyocardial biopsy[J]. Int J Cardiol, 2012, 160(3): 192-195. doi: 10.1016/j.ijcard.2011.04.019 pmid: 21561672
[24]	Ferreira VM, Piechnik SK, Dall’Armellina E, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging[J]. JACC Cardiovasc Imaging, 2013, 6(10): 1048-1058. doi: S1936-878X(13)00539-1 pmid: 24011774
[25]	Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping[J]. Cire Cardiovasc Imaging, 2012, 5(1): 102-110.
[26]	殷亮, 喻思思, 龚良庚. 心脏磁共振纵向弛豫时间定量成像技术进展[J]. 中华放射学杂志, 2016, 50(1): 76-78.
[27]	Park CH, Choi EY, Kwon HM, et al. Quantitative T2 mapping for detecting myocardial edema after reperfusion of myocardial infarction: validation and comparison with T2-weighted images[J]. Int J Cardiovasc Imaging, 2013, 29(suppl 1): 65-72.
[28]	Ding H, Fernandez-de-Manuel L, Schär M, et al. Three-dimensional whole-heart T2 mapping at 3T[J]. Magn Reson Med, 2015, 74(3): 803-816. doi: 10.1002/mrm.25458 pmid: 25242141
[29]	Lee JJ, Liu S, Nacif MS, et al. Myocardial T1 and extracellular volume fraction mapping at 3 tesla[J]. J cardiovasc Magn Reson, 2011, 13(1): 75.
[30]	Kawel N, Nacif M, Zavodni A, et al. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region[J]. J Cardiovasc Magn Reson, 2012, 14(1): 27.
[31]	Nadjiri J, Nieberler H, Hendrich E, et al. Performance of native and contrast- enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques[J]. Int J Cardiovasc Imaging, 2017, 33(4): 539- 547.
[32]	Wassmuth R, Prothmann M, Utz W, et al. Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema[J]. J Cardiovasc Magn Reson, 2013, 15(1): 27.
[33]	刘新峰, 马海彦, 王荣品, 等. T1 mapping和细胞外容积分数技术在急性病毒性心肌炎的临床应用[J]. 实用医学杂志, 2019, 35(5): 800-803.
[34]	Dabir D, Child N, Kalra A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the international T1 multicenter cardiovascular magnetic resonance study[J]. J Cardiovasc Magn Reson, 2014, 16(1): 69.
[35]	Miller CA, Naish JH, Bishop P, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume[J]. Circ Cardiovasc Imaging, 2013, 6(3): 373-383. doi: 10.1161/CIRCIMAGING.112.000192 pmid: 23553570
[36]	Cornicelli MD, Rigsby CK, Rychlik K, et al. Diagnostic performance of cardiovascular magnetic resonance native T1 and T2 mapping in pediatric patients with acute myocarditis[J]. J Cardiovasc Magn Reson, 2019, 21(1): 40.
[37]	Lurz P, Luecke C, Eitel I, et al. Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-trial[J]. J Am Coll Cardiol, 2016, 67(15): 1800-1811. doi: S0735-1097(16)00610-0 pmid: 27081020
[38]	Baeßler B, Schaarschmidt F, Dick A, et al. Mapping tissue inhomogeneity in acute myocarditis: a novel analytical approach to quantitative myocardial edema imaging by T2-mapping[J]. J Cardiovasc Magn Reson, 2015, 17: 115.
[39]	Luetkens JA, Homsi R, Dabir D, et al. Comprehensive cardiac magnetic resonance for short-term follow-up in acute myocarditis[J]. J Am Heart Assoc, 2016, 5(7): e003603.

组别	例数	年龄[M(P₂₅~P₇₅)]/岁	男性[n(%)]	HCT(x±s)/%	心率(x±s)/次·min^-1	ER(x±s)
心肌炎组	29	8.8(4.2~13.4)	16(55.2)	37.4±5.1	84.6±30.9	2.0±0.5
非心肌炎组	50	9.7(6.2~13.2)	27(54.0)	37.9±3.1	79.7±16.8	1.6±0.2
统计量		Z=0.90	χ²=0.01	t=0.49	t=0.79	t=4.20
P		0.373	0.920	0.626	0.435	<0.001

组别	例数	T2 mapping值/ms	T1 native值/ms	T1 enhanced值/ms	ECV/%
心肌炎组	29	60.0±9.5	1 185.7±102.7	469.3±80.2	36.5±7.1
非心肌炎组	50	49.5±5.5	1 027.4±28.8	530.9±64.7	26.4±3.3
t值		5.43	8.12	3.73	7.21
P		<0.001	<0.001	<0.001	<0.001

项目	AUC(95%CI)	P	截断值	灵敏度/%	特异度/%	约登指数
LLC	0.75(0.64~0.84)	<0.001	-	51.7	98.0	0.50
T2 mapping	0.86(0.77~0.93)	<0.001	52.5 ms	79.3	80.0	0.59
T1 native	0.92(0.84~0.97)	<0.001	1 086.0 ms	82.8	100.0	0.83
T1 enhanced	0.70(0.59~0.80)	<0.001	516.5 ms	79.3	54.0	0.33
ECV	0.93(0.85~0.98)	<0.001	30.4%	89.7	96.0	0.86

项目	准确度/%	灵敏度/%	特异度/%	阳性预测值/%	阴性预测值/%
LLC	81.0	51.7	98.0	93.8	77.8
新LLC	92.4	89.7	94.0	89.7	94.0
χ²值	4.45	10.07	1.04	0.00	5.74
P	0.035	0.002	0.307	1.000	0.017

Study on the application value of the new Lake Louise criteria in children with myocarditis

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 39

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689.
[2]	ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697.
[3]	ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704.
[4]	WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711.
[5]	WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720.
[6]	HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726.
[7]	SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732.
[8]	Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608.
[9]	Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621.
[10]	LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627.
[11]	WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635.
[12]	GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643.
[13]	YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650.
[14]	HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488.
[15]	LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498.